Clinical Trial Update: First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the Knee [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluated ascending single intra-articular doses of GZ389988 in patients with painful knee osteoarthritis; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• GZ389988 (GZ389988)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED